Vimarsana
Biggest News Aggregation in the World

Page 6 - Scientific Program Committee News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scientific Program Committee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scientific Program Committee Today - Breaking & Trending Today

LIMIFLEX™ IDE CLINICAL TRIAL INVESTIGATOR TO PRESENT POSITIVE FINDINGS AT THE NORTH AMERICAN SPINE SOCIETY ANNUAL MEETING - Vimarsana News

LIMIFLEX™ IDE CLINICAL TRIAL INVESTIGATOR TO PRESENT POSITIVE FINDINGS AT THE NORTH AMERICAN SPINE SOCIETY ANNUAL MEETING

/PRNewswire/ -- Empirical Spine, Inc., a medical device company creating a new class of spinal implant that works in parallel with the natural structures of...

Radha Rangarajan Is New CSIR-CDRI Director » Glamsham - Vimarsana News

Radha Rangarajan Is New CSIR-CDRI Director » Glamsham

Lucknow, Sep 6 (IANS) Eminent scientist Radha Rangarajan is the new director of CSIR-Central Drug Research Institute (CDRI), Lucknow.

Radha Rangarajan is new CSIR-CDRI director - Vimarsana News

Radha Rangarajan is new CSIR-CDRI director

Eminent scientist Radha Rangarajan is the new director of CSIR-Central Drug Research Institute (CDRI), Lucknow.

Developments in AIU, Plaque Assessment to be Showcased at SCCT2022 - Vimarsana News

Developments in AIU, Plaque Assessment to be Showcased at SCCT2022

The Society of Cardiovascular Computed Tomography (SCCT) has released an update on the device manufacturers set to display their latest technologies at the 2022 Annual Scientific Meeting (SCCT2022) being held in Las Vegas July 15 – 17.

Monoclonal Antibody Shows Promise in Mixed Dyslipidemia - Vimarsana News

Monoclonal Antibody Shows Promise in Mixed Dyslipidemia

Targeting a protein complex that inhibits lipoprotein lipase with a monoclonal antibody lowers both triglycerides and LDL cholesterol while increasing HDL cholesterol, suggests an early-stage trial.